Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort StudyNaomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.ACR Open Rheumatology|December 10, 2021
Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort StudyNaomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|August 18, 2009
Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeabilityUwe Pfeil, Muhammad Aslam, Renate Paddenberg, et al.Nature Communications|September 27, 2024
Universal correlation between H-linear magnetoresistance and T-linear resistivity in high-temperature superconductorsJ Ayres, M Berben, C Duffy, et al.Annals of the Rheumatic Diseases|August 9, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron waveYumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.Nature Communications|July 12, 2023
Expanded quantum vortex liquid regimes in the electron nematic superconductors FeSe<sub>1-x</sub>S<sub>x</sub> and FeSe<sub>1-x</sub>Te<sub>x</sub>M Čulo, S Licciardello, K Ishida, et al.Science (New York, N.Y.)|July 4, 2015
Heavy fermions. Unconventional Fermi surface in an insulating stateB S Tan, Y-T Hsu, B Zeng, et al.Medrxiv : the Preprint Server for Health Sciences|June 29, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronYumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.Arthritis Care & Research|March 21, 2022
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph ScoresNaomi J Patel, Kristin M D'Silva, Matthew D Li, et al.Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.Pageof 7